These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 4564198)

  • 41. [Treatment of thrombophlebitis and lymphedema of the lower extremities with proteolytic enzymes and heparin electrophoresis].
    Matskiv AS
    Vestn Khir Im I I Grek; 1972 Jun; 108(6):79-81. PubMed ID: 5042722
    [No Abstract]   [Full Text] [Related]  

  • 42. [Therapeutic experiences with Hemeran gel and Hemeran paste in the varicose syndrome and hematoma].
    Gycha F; Oesterheld G; Taller A
    Med Welt; 1972 Feb; 9():310-6. PubMed ID: 4111908
    [No Abstract]   [Full Text] [Related]  

  • 43. Dimethyl sulfoxide (DMSO): laboratory and clinical evaluation.
    Jacob SW; Herschler RJ; Rosenbaum EE
    J Am Vet Med Assoc; 1965 Dec; 147(12):1350-9. PubMed ID: 5894316
    [No Abstract]   [Full Text] [Related]  

  • 44. [Bromelines in phlebology].
    Tessler L
    Phlebologie; 1965; 18(2):137-41. PubMed ID: 5829341
    [No Abstract]   [Full Text] [Related]  

  • 45. [Additional results of the management of chronic occlusive conditions and their sequellae using Reparil].
    Wolfram S
    Wien Med Wochenschr; 1968 Sep; 118(39):812. PubMed ID: 5750823
    [No Abstract]   [Full Text] [Related]  

  • 46. [Possibilities of a complex etiologic therapy of veinous diseases].
    Kumpmann U
    Z Allgemeinmed; 1969 Oct; 45(28):1327-31. PubMed ID: 5386120
    [No Abstract]   [Full Text] [Related]  

  • 47. [Treatment of varicose symptom complex in gynecology with Rexiluven].
    Birkhoff HD; Patel K
    Ther Ggw; 1970 Dec; 109(12):1779-80 passim. PubMed ID: 5531367
    [No Abstract]   [Full Text] [Related]  

  • 48. [Use of a minor fibrinolytic drug (mesoglycan) in phlebitis].
    Scondotto G; De Fabritiis A; Guastarobba A; Amato AC; Filippini M
    Minerva Med; 1984 Jul; 75(28-29):1733-8. PubMed ID: 6236381
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dimethyl sulfoxide inhibits tissue factor expression, thrombus formation, and vascular smooth muscle cell activation: a potential treatment strategy for drug-eluting stents.
    Camici GG; Steffel J; Akhmedov A; Schafer N; Baldinger J; Schulz U; Shojaati K; Matter CM; Yang Z; Lüscher TF; Tanner FC
    Circulation; 2006 Oct; 114(14):1512-21. PubMed ID: 17000906
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Conservative treatment of venous diseases in the leg].
    Sigg K
    Med Klin; 1970 May; 65(20):972-7. PubMed ID: 4930599
    [No Abstract]   [Full Text] [Related]  

  • 51. [Varicose veins of the lower extremities. Symptomatic treatment with a new vasculotrophic agent].
    Gomez Trillo JT
    Prensa Med Mex; 1973; 38(7):293-6. PubMed ID: 4596813
    [No Abstract]   [Full Text] [Related]  

  • 52. [Therapy of the varicose symptom complex. Experiences with Rexiluven].
    Seyrek T
    Ther Ggw; 1972 Feb; 111(2):228-41. PubMed ID: 4625541
    [No Abstract]   [Full Text] [Related]  

  • 53. [Hemorrhoids and conservative treatment. Review of the literature on the use of diosmin and micronized hesperidin].
    La Torre F; Nicolai AP; Otti M
    Minerva Chir; 1999 Dec; 54(12):909-16. PubMed ID: 10736998
    [No Abstract]   [Full Text] [Related]  

  • 54. [Short term examination of additional pulpitis agents (combination preparations with dimethyl sulfoxide (DMSO). (2)].
    Triadan H; Thieme E
    SSO Schweiz Monatsschr Zahnheilkd; 1969 May; 79(5):645-50. PubMed ID: 4890090
    [No Abstract]   [Full Text] [Related]  

  • 55. [The therapeutic effects and tolerance of glyvenol in dragees].
    Steinacher J
    Z Haut Geschlechtskr; 1970 Oct; 45(19):647-50. PubMed ID: 5475641
    [No Abstract]   [Full Text] [Related]  

  • 56. Drugs & dosages. The DMSO controversy.
    Occup Health Nurs; 1982 Dec; 30(12):50. PubMed ID: 6760015
    [No Abstract]   [Full Text] [Related]  

  • 57. [Use of dimethyl sulfoxide (DMSO) for treating flexion contractures in rheumatoid arthritis patients].
    Murav'ev IuV; Aliab'eva AP
    Ter Arkh; 1984; 56(9):128-9. PubMed ID: 6515539
    [No Abstract]   [Full Text] [Related]  

  • 58. [Clinical experience with a new compound with vasodynamic and capillaroprotective action in the treatment of venous diseases of the lower limbs].
    Bagliani A; Vittori F
    Minerva Cardioangiol; 1972; 20(7):390-6. PubMed ID: 5050746
    [No Abstract]   [Full Text] [Related]  

  • 59. [Effect of Venoruton in patients with chronic venous insufficiency].
    Roztocil K; Novãk P; Fischer A; Rãzgovã L
    Cesk Dermatol; 1972 Dec; 47(6):256-60. PubMed ID: 4663728
    [No Abstract]   [Full Text] [Related]  

  • 60. A multicentre trial of Zostrum (5 percent idoxuridine in dimethyl sulphoxide) in herpes zoster.
    Burton WJ; Gould PW; Hursthouse MW; Sears PJ; Larnder DA; Stringer HC; Turnbull BC
    N Z Med J; 1981 Nov; 94(696):384-6. PubMed ID: 6459547
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.